Nanjing Hicin Pharmaceutical Co Ltd

300584

Company Profile

  • Business description

    Nanjing Hicin Pharmaceutical Co Ltd is a China-based company engaged in producing pharmaceutical preparations. In addition, it is also involved in manufacturing synthetic chemicals, conducting new drug research and development as well as technical transferring. The company produces series of the medicines such as antivirals, antibiotics, endocrine drugs, gastrointestinal drugs, orthopedic drugs, drugs for the cardio-cerebral system and immuno-modulate agents. The active pharmaceutical ingredients, omeprazole sodium for injection, cefepime hydrochloride for Injection and lansoprazole tablets are exported by the firm into South-Asian countries, South-American countries and European countries.

  • Contact

    Heng Road 1
    Nanjing Economic and Technological Development Zone
    Jiangsu Province
    Nanjing210009
    CHN

    T: +86 2583241383

    http://www.hicin.cn

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    548

Stocks News & Analysis

stocks

PayPal earnings: Growth slows, new CEO appointed

We expect to lower our fair value estimate of PayPal stock.
stocks

Morningstar initiates on ASX income play

This REIT may be an option for investors seeking income.
stocks

What Goodman’s upcoming earnings could reveal about data centre & AI growth

Answering key questions about Goodman & its data centre pipeline ahead of earnings

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,149.306.90-0.08%
CAC 408,179.501.67-0.02%
DAX 4024,780.7916.73-0.07%
Dow JONES (US)49,209.79197.87-0.40%
FTSE 10010,314.5926.97-0.26%
HKSE26,834.7759.200.22%
NASDAQ23,195.00397.11-1.68%
Nikkei 22554,720.662,065.483.92%
NZX 50 Index13,421.529.080.07%
S&P 5006,908.3168.13-0.98%
S&P/ASX 2008,857.109.20-0.10%
SSE Composite Index4,067.7451.991.29%

Market Movers